Navigation Links
Human Pheromone Sciences Announces Quarterly and Full Year Results
Date:3/31/2008

SAN JOSE, Calif., March 31, 2008 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced results for the three months and the year ended December 31, 2007. For the three months ended December 31, 2007, net revenue was $389,000, representing a 6% decrease from revenues of $412,000 in the prior year period, and resulted in net income of $38,000 ($.01 per share) as compared with a net income of $66,000 ($.02 per share) for the same period of 2006. For the full year, net revenues of $1,291,000, were 5% higher than revenues of $1,227,000 generated in the prior year. The net loss in the current year of $16,000 ($.00 per share) was a reduction from the $111,000 loss ($.03 per share) recorded for the full year of 2006.

"In the third and fourth quarters of 2006, we had very large orders from our largest purchaser of pheromones that were not replicated in the current year quarters. As such, for the full year, revenue from pheromone sales were $207,000 (24%) lower than in 2007, while revenues attributable to licensing activities rose by $344,000 (188%) from the prior year. The growth in total revenues in the current year is attributable to the licensing activities. Lower operating expenses, coupled with the revenue growth, gave rise to the improved bottom line in the current year," a spokesperson indicated.

"These cyclical pheromone purchases are unpredictable and, as such, we developed a set of strategic imperatives to grow our licensing revenues, to formulate a program to maximize revenues from our proprietary Natural Attractions(R) brand and to complete human testing on additional novel compounds that can contribute to the expansion of our business through the scientific validation of additional technologies that will enhance the value of our Company," a spokesman noted. "While we are not pleased by the financial results for the current year fourth quarter as compared with the prior ye
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ... today reported results of its Oral Amphotericin B ... reservoirs.  The study, conducted by ImmuneCarta®, the immune ... vitro effectiveness of Oral Amp B in ... in individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... Aug. 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), ... technologies and products for advanced microarray diagnostics, today announced ... August 22 at 2:00 pm ET.  ... provide a brief review of SQI,s recent commercialization progress ... diagnostics industry veteran recently appointed to the Board of ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight is ... HIV infection and the number of deaths due to AIDS ... across the globe. It has been estimated that the death ... 2013, with the rates for children being even much lower. ... rates has been the improved access to antiretroviral drugs and ...
Breaking Biology Technology:Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... tiny man with giant ideas. Ill never forget the one and ... a conference of business executives in Cambridge, Massachusetts. There were one ... for a keynote, Drucker spoke immediately after lunch. He had to ... effortlessly for almost two hours. No Powerpoint. No props. No nonsense. ...
... The City of Madison has been awarded the top ... for Digital Government's 2005 Digital Cities Survey, an ... technology. The annual survey is conducted by the Center ... www.cityofmadison.com , allows visitors access to features such as ...
... and marketers have been hyping any time, anywhere computing for ... starting a technology company, anywhere needs to be spittin distance ... or Boston. You might get away setting up shop in ... well, there is no beyond that. , ,The bias is ...
Cached Biology Technology:Praise for the principles of Peter 2Praise for the principles of Peter 3Praise for the principles of Peter 4Does location matter anymore? 2Does location matter anymore? 3
(Date:8/19/2014)... world, leprosy and tuberculosis live side-by-side. Worldwide there ... year, with nearly all of them occurring where ... Bacille Calmette-Guerin, or BCG, provides only partial protection ... potent vaccine is needed to combat both diseases. ... against both diseases., In a study published in ...
(Date:8/19/2014)... Scientists at the Houston Methodist Research Institute have figured ... using a pipette -- a common laboratory tool that,s ... preliminary test results in a recent issue of the ... "Studying single cells and their unique functions has become ... faculty member Lidong Qin, Ph.D., the project,s principal investigator. ...
(Date:8/19/2014)... UTSA researchers has been awarded a nearly $40,000 grant ... (NCPTT), an office of the National Park Service (NPS) ... fund a one-year study of the energy efficiency and ... in hot, humid climates. , Radiant barriers are reflective ... reflect heat back, thereby reducing the amount of heat ...
Breaking Biology News(10 mins):New vaccine shows promise as stronger weapon against both tuberculosis and leprosy 2Moving single cells around -- accurately and cheaply 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3
... is available in Spanish . , A ... has been released by Agricultural Research Service (ARS) scientists and ... aquatic plant native to South America that has infested freshwater ... in the southeastern United States. The plant is a real ...
... CITY, Calif. and WEST PALM BEACH, Fla. ... global provider of authentication and endpoint protection solutions and ... (EMR) and Discharge Systems for Emergency Rooms and Urgent ... biometrics from DigitalPersona into the ScriptRx System. Designed for ...
... venue for the 3rd Baltic Congress of Osteoporosis which ... to be held in English, is jointly organized by ... Osteoporosis Foundation, Lithuanian Association of Metabolic Bone Diseases and ... most disabling conditions of older adults and elderly. These ...
Cached Biology News:Scientists release biocontrol for water hyacinth 2ScriptRx and DigitalPersona Team Up to Secure Emergency Room and Urgent Care Electronic Medical Records 2ScriptRx and DigitalPersona Team Up to Secure Emergency Room and Urgent Care Electronic Medical Records 3ScriptRx and DigitalPersona Team Up to Secure Emergency Room and Urgent Care Electronic Medical Records 4
... The x2 Dual-Binary Analytical System more than ... LC and LC/MS. The fast analysis cycles ... by up to 100% in tandem mode. ... multi-dimensional mode. Using backflush or heartcut configurations, ...
... for immune complex disruption (ICD) of antigen/antibody ... a combination of low pH and heat. ... to microplate wells which are coated with ... HIV-1 p24. The immobilized monoclonal antibody captures ...
Request Info...
... EVOlyzer is Tecans new Enzyme-Linked Immunosorbent Assay ... Freedom EVOlyzer is a dedicated EVO platform ... reader, washer and incubation units operated by ... EVOlyzer is available in three sizes - ...
Biology Products: